SMYD2 promotes tumorigenesis and metastasis of lung adenocarcinoma through RPS7
Abstract The protein methyltransferase SET and MYND domain-containing protein 2 (SMYD2) is a transcriptional regulator that methylates histones and nonhistone proteins. As an oncogene, SMYD2 has been investigated in numerous types of cancer. However, its involvement in lung cancer remains elusive. T...
Auteurs principaux: | Lei Wu, Fan Kou, Zhenyu Ji, Baihui Li, Bailu Zhang, Yan Guo, Lili Yang |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Nature Publishing Group
2021-05-01
|
Collection: | Cell Death and Disease |
Accès en ligne: | https://doi.org/10.1038/s41419-021-03720-w |
Documents similaires
-
Somatic copy number alterations are predictive of progression-free survival in patients with lung adenocarcinoma undergoing radiotherapy
par: Fan Kou, et autres
Publié: (2022-05-01) -
ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma
par: Zhenyu Zhou, et autres
Publié: (2019-01-01) -
Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis
par: Kwangho Kim, et autres
Publié: (2023-05-01) -
ZNF8 Orchestrates with Smad3 to Promote Lung Metastasis by Recruiting SMYD3 in Breast Cancer
par: Wenwen Geng, et autres
Publié: (2024-10-01) -
Regulation of EZH2 by SMYD2-Mediated Lysine Methylation Is Implicated in Tumorigenesis
par: Yi Zeng, et autres
Publié: (2019-11-01)